 | • レポートコード：QYR9ST04392 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、双極性障害の世界市場について調査・分析し、双極性障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（選択的セロトニン再取り込み阻害剤、セロトニンノルエピネフリン再取り込み阻害剤、三環系抗うつ薬、モノアミンオキシダーゼ阻害剤、ベンゾジアゼピン、ベータ遮断薬）、用途別（気分安定剤、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の双極性障害市場動向 ・主要企業別マーケットシェア ・双極性障害の種類別市場規模2014-2019 （選択的セロトニン再取り込み阻害剤、セロトニンノルエピネフリン再取り込み阻害剤、三環系抗うつ薬、モノアミンオキシダーゼ阻害剤、ベンゾジアゼピン、ベータ遮断薬） ・双極性障害の用途別市場規模2014-2019 （気分安定剤、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬） ・双極性障害の北米市場：主要企業・種類別/用途別市場規模 ・双極性障害のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・双極性障害の中国市場：主要企業・種類別/用途別市場規模 ・双極性障害の日本国内市場：主要企業・種類別/用途別市場規模 ・双極性障害の東南アジア市場：主要企業・種類別/用途別市場規模 ・双極性障害のインド市場：主要企業・種類別/用途別市場規模 ・双極性障害の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Glaxo SmithKline (GSK)、Pfizer、Janssen Pharmaceuticals、Eli Lilly、Allergan、Novartis、AbbVie、Otsuka、AstraZeneca） ・双極性障害の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity levels.People suffering with bipolar disorder have intense emotional states that occur in distinct periods called mood episodes. Mood episode is characterized by drastic changes in person’s usual mood and their behavior. Mood episode is mainly classified into two main types: manic episodes and depressive episodes. An overexcited or joyful state is called a manic episode and an extremely hopeless or sad state is called a depressive episode. Sometimes, a mood episode includes symptoms of both depression and mania, known as mixed state. These mood episodes hamper school and job performance.
In 2018, the global Bipolar Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bipolar Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bipolar Disorder development in United States, Europe and China.
The key players covered in this study
Glaxo SmithKline (GSK)
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
AbbVie
Otsuka
AstraZeneca
Market segment by Type, the product can be split into
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Market segment by Application, split into
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bipolar Disorder status, future forecast, growth opportunity, key market and key players.
To present the Bipolar Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bipolar Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bipolar Disorder Market Size Growth Rate by Type (2014-2025)
1.4.2 Selective Serotonin Reuptake Inhibitor
1.4.3 Serotonin Norepinephrine Reuptake Inhibitors
1.4.4 Tricyclic Antidepressants
1.4.5 Monoamine Oxidase Inhibitors
1.4.6 Benzodiazepines
1.4.7 Beta Blockers
1.5 Market by Application
1.5.1 Global Bipolar Disorder Market Share by Application (2014-2025)
1.5.2 Mood Stabilizers
1.5.3 Anticonvulsants
1.5.4 Antipsychotic drugs
1.5.5 Antidepressant drugs
1.5.6 Antianxiety drugs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bipolar Disorder Market Size
2.2 Bipolar Disorder Growth Trends by Regions
2.2.1 Bipolar Disorder Market Size by Regions (2014-2025)
2.2.2 Bipolar Disorder Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bipolar Disorder Market Size by Manufacturers
3.1.1 Global Bipolar Disorder Revenue by Manufacturers (2014-2019)
3.1.2 Global Bipolar Disorder Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.2 Bipolar Disorder Key Players Head office and Area Served
3.3 Key Players Bipolar Disorder Product/Solution/Service
3.4 Date of Enter into Bipolar Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bipolar Disorder Market Size by Type (2014-2019)
4.2 Global Bipolar Disorder Market Size by Application (2014-2019)
5 United States
5.1 United States Bipolar Disorder Market Size (2014-2019)
5.2 Bipolar Disorder Key Players in United States
5.3 United States Bipolar Disorder Market Size by Type
5.4 United States Bipolar Disorder Market Size by Application
6 Europe
6.1 Europe Bipolar Disorder Market Size (2014-2019)
6.2 Bipolar Disorder Key Players in Europe
6.3 Europe Bipolar Disorder Market Size by Type
6.4 Europe Bipolar Disorder Market Size by Application
7 China
7.1 China Bipolar Disorder Market Size (2014-2019)
7.2 Bipolar Disorder Key Players in China
7.3 China Bipolar Disorder Market Size by Type
7.4 China Bipolar Disorder Market Size by Application
8 Japan
8.1 Japan Bipolar Disorder Market Size (2014-2019)
8.2 Bipolar Disorder Key Players in Japan
8.3 Japan Bipolar Disorder Market Size by Type
8.4 Japan Bipolar Disorder Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bipolar Disorder Market Size (2014-2019)
9.2 Bipolar Disorder Key Players in Southeast Asia
9.3 Southeast Asia Bipolar Disorder Market Size by Type
9.4 Southeast Asia Bipolar Disorder Market Size by Application
10 India
10.1 India Bipolar Disorder Market Size (2014-2019)
10.2 Bipolar Disorder Key Players in India
10.3 India Bipolar Disorder Market Size by Type
10.4 India Bipolar Disorder Market Size by Application
11 Central & South America
11.1 Central & South America Bipolar Disorder Market Size (2014-2019)
11.2 Bipolar Disorder Key Players in Central & South America
11.3 Central & South America Bipolar Disorder Market Size by Type
11.4 Central & South America Bipolar Disorder Market Size by Application
12 International Players Profiles
12.1 Glaxo SmithKline (GSK)
12.1.1 Glaxo SmithKline (GSK) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bipolar Disorder Introduction
12.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2014-2019)
12.1.5 Glaxo SmithKline (GSK) Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bipolar Disorder Introduction
12.2.4 Pfizer Revenue in Bipolar Disorder Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Janssen Pharmaceuticals
12.3.1 Janssen Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bipolar Disorder Introduction
12.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2014-2019)
12.3.5 Janssen Pharmaceuticals Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bipolar Disorder Introduction
12.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bipolar Disorder Introduction
12.5.4 Allergan Revenue in Bipolar Disorder Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bipolar Disorder Introduction
12.6.4 Novartis Revenue in Bipolar Disorder Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bipolar Disorder Introduction
12.7.4 AbbVie Revenue in Bipolar Disorder Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Otsuka
12.8.1 Otsuka Company Details
12.8.2 Company Description and Business Overview
12.8.3 Bipolar Disorder Introduction
12.8.4 Otsuka Revenue in Bipolar Disorder Business (2014-2019)
12.8.5 Otsuka Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Bipolar Disorder Introduction
12.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2014-2019)
12.9.5 AstraZeneca Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bipolar Disorder Key Market Segments
Table Key Players Bipolar Disorder Covered
Table Global Bipolar Disorder Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bipolar Disorder Market Size Market Share by Type 2014-2025
Figure Selective Serotonin Reuptake Inhibitor Figures
Table Key Players of Selective Serotonin Reuptake Inhibitor
Figure Serotonin Norepinephrine Reuptake Inhibitors Figures
Table Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Figure Tricyclic Antidepressants Figures
Table Key Players of Tricyclic Antidepressants
Figure Monoamine Oxidase Inhibitors Figures
Table Key Players of Monoamine Oxidase Inhibitors
Figure Benzodiazepines Figures
Table Key Players of Benzodiazepines
Figure Beta Blockers Figures
Table Key Players of Beta Blockers
Table Global Bipolar Disorder Market Size Growth by Application 2014-2025 (Million US$)
Figure Mood Stabilizers Case Studies
Figure Anticonvulsants Case Studies
Figure Antipsychotic drugs Case Studies
Figure Antidepressant drugs Case Studies
Figure Antianxiety drugs Case Studies
Figure Bipolar Disorder Report Years Considered
Table Global Bipolar Disorder Market Size 2014-2025 (Million US$)
Figure Global Bipolar Disorder Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bipolar Disorder Market Size by Regions 2014-2025 (Million US$)
Table Global Bipolar Disorder Market Size by Regions 2014-2019 (Million US$)
Table Global Bipolar Disorder Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Market Share by Regions 2014-2019
Figure Global Bipolar Disorder Market Share by Regions 2019
Table Market Top Trends
Table Global Bipolar Disorder Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bipolar Disorder Market Share by Manufacturers (2014-2019)
Figure Global Bipolar Disorder Market Share by Manufacturers in 2018
Table Global Bipolar Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bipolar Disorder Product/Solution/Service
Table Date of Enter into Bipolar Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table Global Bipolar Disorder Market Size Share by Type (2014-2019)
Figure Global Bipolar Disorder Market Size Market Share by Type (2014-2019)
Table Global Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table Global Bipolar Disorder Market Size Share by Application (2014-2019)
Figure Global Bipolar Disorder Market Size Market Share by Application (2014-2019)
Figure Global Bipolar Disorder Revenue Market Share by Application in 2018
Figure United States Bipolar Disorder Market Size 2014-2019 (Million US$)
Table United States Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table United States Key Players Bipolar Disorder Market Share (2018-2019)
Table United States Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table United States Bipolar Disorder Market Share by Type (2014-2019)
Table United States Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table United States Bipolar Disorder Market Share by Application (2014-2019)
Figure Europe Bipolar Disorder Market Size 2014-2019 (Million US$)
Table Europe Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table Europe Key Players Bipolar Disorder Market Share (2018-2019)
Table Europe Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table Europe Bipolar Disorder Market Share by Type (2014-2019)
Table Europe Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table Europe Bipolar Disorder Market Share by Application (2014-2019)
Figure China Bipolar Disorder Market Size 2014-2019 (Million US$)
Table China Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table China Key Players Bipolar Disorder Market Share (2018-2019)
Table China Bipolar Disorder Market Size by Type (2014-20189) (Million US$)
Table China Bipolar Disorder Market Share by Type (2014-2019)
Table China Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table China Bipolar Disorder Market Share by Application (2014-2019)
Figure Japan Bipolar Disorder Market Size 2014-2019 (Million US$)
Table Japan Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table Japan Key Players Bipolar Disorder Market Share (2018-2019)
Table Japan Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table Japan Bipolar Disorder Market Share by Type (2014-2019)
Table Japan Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table Japan Bipolar Disorder Market Share by Application (2014-2019)
Figure Southeast Asia Bipolar Disorder Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bipolar Disorder Market Share (2018-2019)
Table Southeast Asia Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bipolar Disorder Market Share by Type (2014-2019)
Table Southeast Asia Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bipolar Disorder Market Share by Application (2014-2019)
Figure India Bipolar Disorder Market Size 2014-2019 (Million US$)
Table India Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table India Key Players Bipolar Disorder Market Share (2018-2019)
Table India Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table India Bipolar Disorder Market Share by Type (2014-2019)
Table India Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table India Bipolar Disorder Market Share by Application (2014-2019)
Figure Central & South America Bipolar Disorder Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bipolar Disorder Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bipolar Disorder Market Share (2018-2019)
Table Central & South America Bipolar Disorder Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bipolar Disorder Market Share by Type (2014-2019)
Table Central & South America Bipolar Disorder Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bipolar Disorder Market Share by Application (2014-2019)
Table Glaxo SmithKline (GSK) Company Details
Table Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2014-2019) (Million US$)
Figure Glaxo SmithKline (GSK) Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Glaxo SmithKline (GSK) Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Pfizer Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Eli Lilly Recent Development
Table Allergan Company Details
Table Allergan Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Allergan Recent Development
Table Novartis Company Details
Table Novartis Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Novartis Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table AbbVie Recent Development
Table Otsuka Company Details
Table Otsuka Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure Otsuka Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table Otsuka Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Bipolar Disorder Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Bipolar Disorder Business (2014-2019)
Table AstraZeneca Recent Development
Table Global Bipolar Disorder Market Size by Regions (Million US$) 2019-2025
Figure Global Bipolar Disorder Market Size Share by Regions (2019-2025)
Figure Global Bipolar Disorder Market Size Share by Regions in 2025
Figure United States Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Figure China Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Figure India Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bipolar Disorder Market Size Forecast (2019-2025)(Million USD)
Table Global Bipolar Disorder Market Size by Product (2019-2025) (Million US$)
Figure Global Bipolar Disorder Market Size by Product (2019-2025)
Figure Global Bipolar Disorder Market Size by Product in 2025
Table Global Bipolar Disorder Market Size by Application (2019-2025) (Million US$)
Figure Global Bipolar Disorder Market Size by Application (2019-2025)
Figure Global Bipolar Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…- 抗うつ薬の世界市場：インサイト・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps i…
- 抗うつ薬の世界市場：インサイト・予測 Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperact…
- 世界の双極性障害治療薬市場：動向・競争分析 Bipolar disorder, also known as manic-depressive disorder, is a combination of manic, hypomanic and depressive episodes.The ultimate goal of therapeutic agents for bipolar disorder is to improve patients' quality of life and maintain good social function as much as possible.The Bipolar Disorder Ther…
- 認知症および運動障害の治療の世界市場：市場規模・現状・予測 Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…